When coronary artery disease becomes severe — multiple blockages, critical narrowing, or involvement of major vessels — two treatment options are considered: angioplasty (also called PCI or percutaneous coronary intervention) and bypass surgery (CABG, or coronary artery bypass grafting).
Both procedures restore blood flow to the heart muscle, but they do so in fundamentally different ways. The right choice depends on the number and location of blockages, the patient’s overall health, heart function and other clinical factors. This article explains how each procedure works, compares them head to head, and outlines when one is preferred over the other.
What Is CABG (Coronary Artery Bypass Grafting)?
CABG — commonly referred to as bypass surgery or open-heart surgery — is a major surgical procedure in which a cardiac surgeon creates new routes for blood to reach the heart muscle, bypassing the blocked segments of the coronary arteries.
The surgeon uses healthy blood vessels (called grafts) harvested from other parts of the body:
- Internal mammary artery (IMA): Taken from the chest wall. The left IMA (LIMA) grafted to the left anterior descending (LAD) artery is the gold standard — it has excellent long-term patency rates exceeding 90% at 10 years.
- Saphenous vein: Harvested from the leg. Vein grafts are commonly used for other coronary arteries but have lower long-term patency compared to arterial grafts.
- Radial artery: Taken from the forearm. Used as an additional arterial graft in selected patients, with good long-term outcomes.
The procedure is performed under general anaesthesia, typically through a midline sternotomy (an incision through the breastbone). Most CABG surgeries are done with a heart-lung machine (on-pump), though off-pump (beating heart) surgery is also performed in selected cases. The surgery usually takes 3–5 hours depending on the number of grafts required.
CABG can address multiple blockages in a single operation and is particularly effective when the disease is diffuse or involves the left main coronary artery.
What Is Angioplasty (PCI)?
Angioplasty, or percutaneous coronary intervention, is a minimally invasive catheter-based procedure. A thin tube is inserted through the wrist or groin artery, guided to the blocked coronary artery, and a balloon is inflated to open the narrowing. A stent — a small metallic scaffold — is then placed to keep the artery open.
The procedure is done under local anaesthesia with sedation, takes 30–90 minutes, and most patients are discharged within 24–48 hours. For a detailed explanation, see our guide on angioplasty and stenting for blocked heart arteries.
CABG vs Angioplasty: Head-to-Head Comparison
The following table summarises how bypass surgery and angioplasty compare across the key parameters that matter to patients and families:
| Parameter | CABG (Bypass Surgery) | Angioplasty (PCI) |
|---|---|---|
| Procedure type | Open-heart surgery (sternotomy) | Minimally invasive (catheter-based) |
| Anaesthesia | General anaesthesia | Local anaesthesia with sedation |
| Hospital stay | 7–10 days | 1–3 days |
| Recovery time | 6–8 weeks | 1–2 weeks |
| Blockages addressed | Multiple vessels in one operation | Best for 1–2 vessels; multi-vessel possible in stages |
| Durability | LIMA graft: >90% open at 10 years; vein grafts: 50–60% at 10 years | Drug-eluting stents: ~85–90% open at 5 years |
| Repeat procedure rate | Lower (5–10% at 5 years) | Higher (10–15% at 5 years) |
| Peri-procedural risk | Higher surgical risk (1–3% mortality) | Lower procedural risk (<1% mortality) |
| Best suited for | Triple-vessel disease, left main disease, diabetics with multi-vessel disease, low EF | Single/double vessel disease, acute heart attack, high surgical risk patients |
Note: Outcomes depend on individual patient factors, operator experience and institutional volume. The figures above represent general trends from large clinical trials and registries.
When Is CABG (Bypass Surgery) Recommended?
Current clinical guidelines and trial evidence support CABG as the preferred option in the following situations:
- Triple-vessel disease (TVD): When all three major coronary arteries — LAD, circumflex and right coronary artery — have significant blockages. CABG provides more complete revascularisation and better long-term survival than multi-vessel PCI in most studies.
- Left main coronary artery disease: The left main artery supplies the majority of the heart’s blood flow. Significant blockage here is high-risk, and CABG has been the standard treatment. (PCI is now an option for selected left main cases with lower SYNTAX scores, but CABG remains preferred for complex anatomy.)
- Diabetes with multi-vessel disease: The FREEDOM trial demonstrated that diabetic patients with multi-vessel coronary disease had significantly better long-term outcomes with CABG compared to PCI — lower rates of death and heart attack at 5 years.
- Reduced heart function (low ejection fraction): Patients with an EF below 35–40% and multi-vessel disease often benefit more from CABG, which provides more complete blood flow restoration and has shown survival benefit in this group.
- Failed or unsuitable angioplasty: If a previous stent has failed (in-stent restenosis or stent thrombosis), or the coronary anatomy is not suitable for stenting (diffuse disease, heavy calcification, chronic total occlusions), CABG may be the better option.
Key point: The decision between CABG and angioplasty should always be made by a Heart Team — a collaborative discussion between the interventional cardiologist, cardiac surgeon and the patient. This is recommended by all major cardiology guidelines worldwide.
When Is Angioplasty (PCI) Preferred?
Angioplasty is the preferred or equivalent option in the following clinical scenarios:
- Single or double vessel disease: When one or two coronary arteries are blocked (and the LAD is not the proximal segment), angioplasty with drug-eluting stents provides excellent results comparable to CABG, with faster recovery and lower procedural risk.
- Acute heart attack (primary PCI): During an ST-elevation myocardial infarction (STEMI), emergency angioplasty is the treatment of choice. The blocked artery needs to be opened within 90 minutes of hospital arrival. CABG is not feasible in this emergency setting.
- High surgical risk patients: Elderly patients, those with severe lung disease, kidney failure, previous chest surgery, or other conditions that make open-heart surgery high-risk may be better served by angioplasty.
- Patient preference with suitable anatomy: When the coronary anatomy is suitable for either procedure (for example, left main disease with a low SYNTAX score), some patients prefer the less invasive option after a thorough discussion of risks and benefits.
- Low SYNTAX score (≤22): Clinical trials have shown that in patients with multi-vessel or left main disease and a low SYNTAX score, PCI outcomes are comparable to CABG at 5 years, making angioplasty a reasonable alternative.
The SYNTAX Score: How Doctors Decide Between CABG and Angioplasty
The SYNTAX score is a tool used by cardiologists to objectively assess the complexity of coronary artery disease based on the angiogram (the X-ray images of the arteries taken during a catheterisation procedure). It takes into account the number of blockages, their location, severity, calcification, and the presence of chronic total occlusions or bifurcation lesions.
| SYNTAX Score | Complexity | Recommended Approach |
|---|---|---|
| 0–22 | Low | PCI and CABG have comparable outcomes; either is reasonable |
| 23–32 | Intermediate | CABG generally preferred; PCI may be considered with Heart Team discussion |
| ≥33 | High | CABG strongly recommended; superior long-term outcomes over PCI |
The SYNTAX score is one of the most important tools guiding this decision, but it is not the only factor. Age, diabetes, kidney function, lung disease, previous surgeries, patient preference and frailty all influence the final recommendation. The SYNTAX II score adds these clinical variables for a more individualised assessment.
Cost Comparison: CABG vs Angioplasty in Delhi
Cost is a practical consideration for many families. Here is an approximate comparison for Delhi NCR in 2026:
| Procedure | Government Hospital | Private Hospital |
|---|---|---|
| Angioplasty (single vessel, 1 stent) | Rs 75,000 – 1,50,000 | Rs 2,00,000 – 4,00,000 |
| Angioplasty (multi-vessel, 2–3 stents) | Rs 1,20,000 – 2,50,000 | Rs 3,00,000 – 6,00,000 |
| CABG (bypass surgery) | Rs 2,50,000 – 6,00,000 | Rs 4,00,000 – 10,00,000 |
While angioplasty has a lower upfront cost, patients with complex multi-vessel disease who undergo PCI may need repeat procedures or additional stents over time, which can increase the cumulative cost. CABG, though more expensive initially, often provides more durable revascularisation and may require fewer re-interventions.
For a detailed breakdown of angioplasty costs including stent pricing, insurance coverage and government schemes, see our article on angioplasty cost in Delhi.
Recovery Comparison
The recovery timeline is one of the most significant practical differences between the two procedures:
Angioplasty Recovery
- Hospital stay: 1–3 days
- Return to light activity: 2–3 days
- Return to work (desk job): 1 week
- Full recovery: 1–2 weeks
- Wrist/groin access site heals in 1–2 weeks
- Driving: typically safe after 1 week
CABG Recovery
- Hospital stay: 7–10 days (including ICU)
- Sternal precautions: 6–8 weeks (no lifting >2 kg)
- Return to work (desk job): 6–8 weeks
- Full recovery: 3 months
- Sternotomy wound heals in 6–8 weeks
- Driving: typically after 6–8 weeks
Long-Term Outcomes and Medications
Both CABG and angioplasty are effective at relieving angina (chest pain) and improving quality of life. The differences emerge in long-term outcomes, particularly in patients with complex disease:
- Survival: In multi-vessel disease and diabetes, large trials (SYNTAX, FREEDOM, BEST) have consistently shown a survival advantage for CABG at 5–10 years. In simpler disease (low SYNTAX score), survival is similar between the two.
- Heart attack prevention: CABG grafts bypass the diseased segment entirely, offering protection against future heart attacks from that vessel — even from new blockages that develop downstream of the graft origin. Stents treat the existing blockage only.
- Need for repeat procedures: Patients who undergo PCI have a higher rate of repeat revascularisation (10–15% at 5 years) compared to CABG (5–10%), though modern drug-eluting stents have narrowed this gap.
- Stroke risk: CABG carries a slightly higher risk of peri-operative stroke (1–2%) compared to PCI (<0.5%), which is a relevant consideration in elderly patients.
Medications After Each Procedure
Regardless of which procedure is performed, lifelong cardiac medications are essential:
- After angioplasty: Dual antiplatelet therapy (aspirin + clopidogrel/prasugrel/ticagrelor) for 6–12 months, followed by lifelong aspirin. Statins, blood pressure medications and other drugs as prescribed.
- After CABG: Lifelong aspirin, statins, blood pressure medications. Dual antiplatelet therapy is generally needed for a shorter duration (or not at all) compared to PCI.
Important: After either procedure, lifestyle modifications are critical — regular exercise, a heart-healthy diet, smoking cessation, weight management and diabetes/blood pressure control. Surgery or stenting treats the existing blockages but does not cure the underlying disease. Continued medical therapy and risk factor control are essential to prevent progression.
Frequently Asked Questions
Is bypass surgery more dangerous than angioplasty?
CABG is a major surgery and carries a higher immediate procedural risk (1–3% mortality) compared to angioplasty (<1%). However, in patients with complex multi-vessel disease or diabetes, CABG provides better long-term survival and fewer repeat procedures. The short-term risk of CABG must be weighed against its long-term benefits — which is why the decision should be made by a Heart Team based on your specific anatomy and health status.
Can angioplasty be done after bypass surgery?
Yes. If bypass grafts develop blockages over time, or if new blockages develop in the native coronary arteries, angioplasty can be performed. Stenting of a diseased vein graft or a native coronary artery is a well-established procedure. In some cases, angioplasty is preferred over redo bypass surgery because a second open-heart operation carries higher risk.
How long does a bypass graft last?
The internal mammary artery (LIMA) graft has the best durability — more than 90% remain open at 10 years, and many last 15–20 years or longer. Saphenous vein grafts have lower long-term patency: approximately 60–70% are open at 10 years, and around 50% at 15 years. This is why surgeons prefer to use arterial grafts whenever possible, especially to the LAD artery.
Can I avoid both procedures entirely?
In some cases, yes. If the blockages are not severe (less than 70% narrowing in non-critical arteries), or if there is no evidence of reduced blood flow to the heart, medical therapy alone — statins, antiplatelets, blood pressure medications, lifestyle changes — may be sufficient. The ISCHEMIA trial showed that in stable coronary disease with moderate blockages, an initial strategy of medical therapy was as effective as early intervention. However, this must be assessed on an individual basis with proper stress testing and imaging.
What if I have diabetes — which procedure is better?
For diabetic patients with multi-vessel coronary disease, CABG is generally the recommended option. The FREEDOM trial, which enrolled over 1,900 diabetic patients, showed that CABG resulted in significantly lower rates of death and heart attack at 5 years compared to PCI with drug-eluting stents. Diabetes accelerates coronary disease progression, and the more complete revascularisation provided by CABG offers better long-term protection. However, for diabetic patients with single-vessel disease or during a heart attack, angioplasty remains the appropriate choice.
The Bottom Line
Neither CABG nor angioplasty is universally superior — each has clear advantages in specific clinical situations. Angioplasty offers faster recovery, lower immediate risk and is the treatment of choice during a heart attack and for simpler coronary disease. CABG provides more complete and durable revascularisation, better long-term outcomes in complex multi-vessel disease and diabetes, and remains the gold standard for left main and triple-vessel disease.
The most important step is to have your angiogram reviewed by both an interventional cardiologist and a cardiac surgeon, discuss your SYNTAX score and overall risk profile, and make an informed decision together with your Heart Team.
Related reading
About Dr. Abhinav Aggarwal
Dr Abhinav Aggarwal is an Interventional Cardiologist practising at CardioSight Clinic, Rohini, Delhi. He performs angioplasty and coronary stenting at Fortis Hospital, Shalimar Bagh, and provides comprehensive care for patients with coronary artery disease, including guidance on when bypass surgery or angioplasty is the most appropriate option.
If you need a second opinion on your angiography report, help understanding your SYNTAX score, or a clear discussion on whether bypass surgery or angioplasty is right for your situation, a consultation can help you make an informed decision.
Book an Appointment arrow_forwardThis article is intended for general patient education and does not replace a professional medical consultation. The costs mentioned are approximate ranges for Delhi NCR in 2026 and may vary between hospitals and individual cases. Treatment decisions should be based on a comprehensive evaluation by your cardiologist and cardiac surgeon.